Breast Cancer Vaccine: Human Trials Testing Designed for Triple-Negative Breast Cancers

The Cleveland Clinic proclaimed on Tuesday that it will begin the first clinical study testing a shot intended to avoid triple-negative breast cancer, which presently does not react to hormone or aimed prescribed medications and could only precluded through mastectomy.